CANNAPHARMARX, INC.: 10-Q filed 2021-11-15

Name: CANNAPHARMARX, INC.: 10-Q filed 2021-11-15
Creator: CANNAPHARMARX, INC.

What CANNAPHARMARX, INC. reported in its quarterly report filed 2021-11-15 (fiscal Q3 2021): 35 published measures, 104 facts as tagged in accession 0001683168-21-005633.

This filing

Form: 10-Q (quarterly report)
Filed: 2021-11-15
Fiscal period: fiscal Q3 2021
Accession: 0001683168-21-005633 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CANNAPHARMARX, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2021-09-30	7,039,140	USD
At 2020-12-31	8,747,591	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2021-09-30	13,326,813	USD
At 2020-12-31	17,549,190	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2021-09-30	-6,287,673	USD
At 2021-06-30	-6,394,290	USD
At 2021-03-31	-6,850,337	USD
At 2020-12-31	-8,801,599	USD
At 2020-09-30	1,461,067	USD
At 2020-06-30	2,726,536	USD
At 2020-03-31	1,347,534	USD
At 2019-12-31	4,854,198	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2021-09-30	112,822	USD
At 2020-12-31	334,969	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	-1,029,605	USD	92
2021-01-01 to 2021-09-30	-1,497,040	USD	273
2021-04-01 to 2021-06-30	-1,665,409	USD	91
2021-01-01 to 2021-03-31	1,197,974	USD	90
2020-07-01 to 2020-09-30	-2,652,790	USD	92
2020-01-01 to 2020-09-30	-8,340,088	USD	274
2020-04-01 to 2020-06-30	-1,472,479	USD	91
2020-01-01 to 2020-03-31	-4,214,818	USD	91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2021-01-01 to 2021-09-30	-2,087,367	USD	273
2020-01-01 to 2020-09-30	-832,322	USD	274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Unit	Days
2021-07-01 to 2021-09-30	USD	92
2021-01-01 to 2021-09-30	USD	273
2020-07-01 to 2020-09-30	USD	92
2020-01-01 to 2020-09-30	USD	274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2021-01-01 to 2021-09-30	1,111,709	USD	273
2020-01-01 to 2020-09-30	926,276	USD	274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2021-01-01 to 2021-09-30	493,654	USD	273
2020-01-01 to 2020-09-30	95,681	USD	274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2021-09-30	-78,828,860	USD
At 2020-12-31	-77,331,820	USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	84,415,273	shares	92
2021-01-01 to 2021-09-30	63,364,348	shares	273
2020-07-01 to 2020-09-30	39,720,700	shares	92
2020-01-01 to 2020-09-30	42,583,650	shares	274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2021-07-01 to 2021-09-30	USD	92
2021-01-01 to 2021-09-30	USD	273
2020-07-01 to 2020-09-30	USD	92
2020-01-01 to 2020-09-30	USD	274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2021-09-30	6,755	USD
At 2020-12-31	1,568,751	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	96,700	USD	92
2021-01-01 to 2021-09-30	290,099	USD	273
2020-07-01 to 2020-09-30	204,600	USD	92
2020-01-01 to 2020-09-30	617,758	USD	274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	-771,203	USD	92
2021-01-01 to 2021-09-30	-2,288,628	USD	273
2020-07-01 to 2020-09-30	-1,312,790	USD	92
2020-01-01 to 2020-09-30	-4,670,284	USD	274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2021-09-30	281,606	USD
At 2020-12-31	467,551	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	260,106	USD	92
2021-01-01 to 2021-09-30	1,298,826	USD	273
2020-07-01 to 2020-09-30	358,950	USD	92
2020-01-01 to 2020-09-30	1,719,651	USD	274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2021-09-30	13,326,813	USD
At 2020-12-31	17,549,190	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2021-09-30	3,123,200	USD
At 2020-12-31	3,584,999	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	771,203	USD	92
2021-01-01 to 2021-09-30	2,288,628	USD	273
2020-07-01 to 2020-09-30	1,312,790	USD	92
2020-01-01 to 2020-09-30	4,670,284	USD	274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2021-09-30	95,348,472	shares
At 2020-12-31	46,986,794	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2021-09-30	72,321,722	USD
At 2020-12-31	68,336,249	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2021-09-30	-330,486	USD
At 2020-12-31	-345,714	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2021-09-30	11,099	USD
At 2020-12-31	1,571,186	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2021-09-30	4,344	USD
At 2020-12-31	2,435	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	-1,029,605	USD	92
2021-01-01 to 2021-09-30	-1,497,040	USD	273
2020-07-01 to 2020-09-30	-2,652,790	USD	92
2020-01-01 to 2020-09-30	-8,340,088	USD	274

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	-840,757	USD	92
2021-01-01 to 2021-09-30	-1,481,812	USD	273
2020-07-01 to 2020-09-30	-2,706,496	USD	92
2020-01-01 to 2020-09-30	-8,447,587	USD	274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	170,906	USD	92
2021-01-01 to 2021-09-30	679,052	USD	273
2020-07-01 to 2020-09-30	575,585	USD	92
2020-01-01 to 2020-09-30	803,835	USD	274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2021-01-01 to 2021-09-30	1,946	USD	273
2020-01-01 to 2020-09-30	1,146	USD	274

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2021-01-01 to 2021-09-30	0	USD	273
2020-01-01 to 2020-09-30	98,304	USD	274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	-258,402	USD	92
2021-01-01 to 2021-09-30	791,588	USD	273
2020-07-01 to 2020-09-30	-1,340,000	USD	92
2020-01-01 to 2020-09-30	-3,669,804	USD	274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2021-01-01 to 2021-09-30	0	USD	273
2020-01-01 to 2020-09-30	14,744	USD	274

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2021-01-01 to 2021-09-30	0	USD	273
2020-01-01 to 2020-09-30	0	USD	274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2021-01-01 to 2021-09-30	291,064	USD	273
2020-01-01 to 2020-09-30	0	USD	274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2021-01-01 to 2021-09-30	1,035	USD	273
2020-01-01 to 2020-09-30	-26,954	USD	274

Inspect the source

Entity: CANNAPHARMARX, INC. / CIK 0001081938
Captured: 2026-09-20T05:20:43.396Z
SEC response SHA-256: 5d42938250dbbcfa19092cae39e1ddd591085d080af4dafac930684703fc6a67

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001081938.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))